% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Brhlmann:274135,
author = {S. A. Brühlmann and M. Walther and M. Kreller and F.
Reissig and H.-J. Pietzsch and T. Kniess and K. Kopka$^*$},
title = {{C}yclotron-{B}ased {P}roduction of 67{C}u for
{R}adionuclide {T}heranostics via the 70{Z}n(p,α)67{C}u
{R}eaction},
journal = {Pharmaceuticals},
volume = {16},
number = {2},
issn = {1424-8247},
address = {Basel},
publisher = {MDPI},
reportid = {DKFZ-2023-00445},
pages = {314},
year = {2023},
abstract = {Theranostic matched pairs of radionuclides have aroused
interest during the last couple ofyears, and in that sense,
copper is one element that has a lot to offer, and although
61Cu and 64Cu areslowly being established as diagnostic
radionuclides for PET, the availability of the therapeutic
counterpart 67Cu plays a key role for further
radiopharmaceutical development in the future. Until now,the
67Cu shortage has not been solved; however, different
production routes are being explored. Thisproject aims at
the production of no-carrier-added 67Cu with high
radionuclidic purity with a medical30 MeV compact cyclotron
via the 70Zn(p,α)67Cu reaction. With this purpose, proton
irradiation ofelectrodeposited 70Zn targets was performed
followed by two-step radiochemical separation based
onsolid-phase extraction. Activities of up to 600 MBq 67Cu
at end of bombardment, with radionuclidicpurities over
$99.5\%$ and apparent molar activities of up to 80 MBq/nmol,
were quantified.},
cin = {DD01},
ddc = {610},
cid = {I:(DE-He78)DD01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
doi = {10.3390/ph16020314},
url = {https://inrepo02.dkfz.de/record/274135},
}